CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 61  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1553
LYS 10.0728
GLU 20.1553
LEU 30.0349
ARG 40.0313
CYS 50.0135
GLN 60.0174
CYS 70.0211
ILE 80.0296
LYS 90.0289
THR 100.0124
TYR 110.0068
SER 120.0123
LYS 130.0281
PRO 140.0252
PHE 150.0110
HIS 160.0090
PRO 170.0063
LYS 180.0082
PHE 190.0113
ILE 200.0107
LYS 210.0114
GLU 220.0159
LEU 230.0108
ARG 240.0184
VAL 250.0135
ILE 260.0190
GLU 270.0435
SER 280.0495
GLY 290.0786
PRO 300.0271
HIS 310.0384
CYS 320.0232
ALA 330.0234
ASN 340.0109
THR 350.0181
GLU 360.0128
ILE 370.0071
ILE 380.0111
VAL 390.0068
LYS 400.0115
LEU 410.0104
SER 420.0087
ASP 430.0206
GLY 440.0092
ARG 450.0079
GLU 460.0066
LEU 470.0080
CYS 480.0082
LEU 490.0072
ASP 500.0107
PRO 510.0160
LYS 520.0154
GLU 530.0075
ASN 540.0111
TRP 550.0185
VAL 560.0132
GLN 570.0179
ARG 580.0191
VAL 590.0080
VAL 600.0066
GLU 610.0064
LYS 620.0085
PHE 630.0058
LEU 640.0050
LYS 650.0194
ARG 660.0139
ALA 670.0159
GLU 680.0154
ASN 690.0185

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.